Canadian researchers develop portable device to monitor HIV in rural areas

A team of Canadian researchers has "created a portable device that uses a computer chip with software capable of analyzing blood tests outside the lab ... that could make it easier, faster and cheaper to track the progression of HIV in patients living in the developing world," Postmedia News/Vancouver Sun reports. According to the news service, "The team's portable cell analyzer makes it possible for health care workers to monitor HIV patients in remote areas by testing their blood on the spot and receiving results within minutes, [University of Toronto lead researcher Rakesh] Nayyar explained."

"Most machines currently ... used to analyze patients' blood for a range of disease markers, including those used to test HIV patients, are a bit larger than a microwave, but no bigger than a dishwasher," James Dou, a PhD candidate on the research team said, the news service notes. "In North America, the machines can cost upwards of $100,000, Nayyar said, though they may cost as little as $35,000 in Africa," Postmedia writes, noting that the portable cell analyzer "would cost about $5,000 to $10,000 each, with each test costing only a few dollars to process." The researchers aim to "have the hand-held version ready by March in hopes of sending up to 100 portable cell analyzers to Malawi and Thailand for use in the field by mid-2012, Dou said," the news service writes (Roberts, 12/12).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Historical redlining continues to affect HIV treatment in affected communities